123 related articles for article (PubMed ID: 36730221)
1. Use of Trametinib in Children and Young Adults With Progressive Low-grade Glioma and Glioneuronal Tumors.
Hanzlik E; Archambault B; El-Dairi M; Schroeder K; Patel MP; Lipp ES; Peters KB; Ashley DM; Landi D
J Pediatr Hematol Oncol; 2023 May; 45(4):e464-e470. PubMed ID: 36730221
[TBL] [Abstract][Full Text] [Related]
2. Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma.
Manoharan N; Choi J; Chordas C; Zimmerman MA; Scully J; Clymer J; Filbin M; Ullrich NJ; Bandopadhayay P; Chi SN; Yeo KK
J Neurooncol; 2020 Sep; 149(2):253-262. PubMed ID: 32780261
[TBL] [Abstract][Full Text] [Related]
3. Response to trametinib treatment in progressive pediatric low-grade glioma patients.
Selt F; van Tilburg CM; Bison B; Sievers P; Harting I; Ecker J; Pajtler KW; Sahm F; Bahr A; Simon M; Jones DTW; Well L; Mautner VF; Capper D; Hernáiz Driever P; Gnekow A; Pfister SM; Witt O; Milde T
J Neurooncol; 2020 Sep; 149(3):499-510. PubMed ID: 33026636
[TBL] [Abstract][Full Text] [Related]
4. Trametinib-based Treatment of Pediatric CNS Tumors: A Single Institutional Experience.
Paul MR; Pehlivan KC; Milburn M; Yeh-Nayre L; Elster J; Crawford JR
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e730-e737. PubMed ID: 32398601
[TBL] [Abstract][Full Text] [Related]
5. Trametinib for progressive pediatric low-grade gliomas.
Kondyli M; Larouche V; Saint-Martin C; Ellezam B; Pouliot L; Sinnett D; Legault G; Crevier L; Weil A; Farmer JP; Jabado N; Perreault S
J Neurooncol; 2018 Nov; 140(2):435-444. PubMed ID: 30097824
[TBL] [Abstract][Full Text] [Related]
6. Trametinib therapy for children with neurofibromatosis type 1 and life-threatening plexiform neurofibroma or treatment-refractory low-grade glioma.
Ronsley R; Hounjet CD; Cheng S; Rassekh SR; Duncan WJ; Dunham C; Gardiner J; Ghag A; Ludemann JP; Wensley D; Rehmus W; Sargent MA; Hukin J
Cancer Med; 2021 Jun; 10(11):3556-3564. PubMed ID: 33939292
[TBL] [Abstract][Full Text] [Related]
7. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Bale TA; Rosenblum MK
Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy for pediatric low-grade glioma.
Pérez JPM; Muchart J; López VS; Capella MS; Salvador N; Jaume SP; Martínez OC; La Madrid AM
Childs Nerv Syst; 2021 Aug; 37(8):2511-2520. PubMed ID: 33864514
[TBL] [Abstract][Full Text] [Related]
9. Early experience with targeted therapy as a first-line adjuvant treatment for pediatric low-grade glioma.
Leclair NK; Lambert W; Roche K; Gillan E; Gell JJ; Lau CC; Wrubel G; Knopf J; Amin S; Anderson M; Martin JE; Bookland MJ; Hersh DS
Neurosurg Focus; 2022 Dec; 53(6):E15. PubMed ID: 36455272
[TBL] [Abstract][Full Text] [Related]
10. Report of effective trametinib therapy in 2 children with progressive hypothalamic optic pathway pilocytic astrocytoma: documentation of volumetric response.
Miller C; Guillaume D; Dusenbery K; Clark HB; Moertel C
J Neurosurg Pediatr; 2017 Mar; 19(3):319-324. PubMed ID: 28009226
[TBL] [Abstract][Full Text] [Related]
11. Dabrafenib plus trametinib in patients with BRAF
Wen PY; Stein A; van den Bent M; De Greve J; Wick A; de Vos FYFL; von Bubnoff N; van Linde ME; Lai A; Prager GW; Campone M; Fasolo A; Lopez-Martin JA; Kim TM; Mason WP; Hofheinz RD; Blay JY; Cho DC; Gazzah A; Pouessel D; Yachnin J; Boran A; Burgess P; Ilankumaran P; Gasal E; Subbiah V
Lancet Oncol; 2022 Jan; 23(1):53-64. PubMed ID: 34838156
[TBL] [Abstract][Full Text] [Related]
12. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.
Thomas DL
Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356
[TBL] [Abstract][Full Text] [Related]
13. Sustained Tumor Control With MAPK Inhibition in
Berzero G; Bellu L; Baldini C; Ducray F; Guyon D; Eoli M; Silvani A; Dehais C; Idbaih A; Younan N; Nguyen-Them L; Gaillard S; Pasqualetti F; Lepage-Seydoux C; Sekkate S; Tresca P; Kas A; Gratieux J; Ammari S; Saragoussi E; Savatovsky J; Delattre JY; Hoang-Xuan K; Meyronet D; Villa C; Bielle F; Sanson M; Touat M; Di Stefano AL
Neurology; 2021 Aug; 97(7):e673-e683. PubMed ID: 34088874
[TBL] [Abstract][Full Text] [Related]
14. Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.
Liu APY; Hastings C; Wu S; Bass JK; Heitzer AM; Ashford J; Vestal R; Hoehn ME; Ghazwani Y; Acharya S; Conklin HM; Boop F; Merchant TE; Gajjar A; Qaddoumi I
Cancer; 2019 Apr; 125(7):1163-1175. PubMed ID: 30620400
[TBL] [Abstract][Full Text] [Related]
15. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J; Onar-Thomas A; Young Poussaint T; Wu S; Ligon AH; Lindeman N; Banerjee A; Packer RJ; Kilburn LB; Goldman S; Pollack IF; Qaddoumi I; Jakacki RI; Fisher PG; Dhall G; Baxter P; Kreissman SG; Stewart CF; Jones DTW; Pfister SM; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Fisher MJ; Doyle LA; Smith M; Dunkel IJ; Fouladi M
Lancet Oncol; 2019 Jul; 20(7):1011-1022. PubMed ID: 31151904
[TBL] [Abstract][Full Text] [Related]
16. Update on Circumscribed Gliomas and Glioneuronal Tumors.
Chen J; Dahiya SM
Surg Pathol Clin; 2020 Jun; 13(2):249-266. PubMed ID: 32389265
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience.
Cacciotti C; Choi J; Alexandrescu S; Zimmerman MA; Cooney TM; Chordas C; Clymer J; Chi S; Yeo KK
J Neurooncol; 2020 Aug; 149(1):113-122. PubMed ID: 32627129
[TBL] [Abstract][Full Text] [Related]
18. Clinical response to dabrafenib plus trametinib in a pediatric ganglioglioma with
Miller KE; Schieffer KM; Grischow O; Rodriguez DP; Cottrell CE; Leonard JR; Finlay JL; Mardis ER
Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33637608
[TBL] [Abstract][Full Text] [Related]
19. Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas.
Mitchell AE; Elder JE; Mackey DA; Waters KD; Ashley DM
J Pediatr Hematol Oncol; 2001 Dec; 23(9):572-7. PubMed ID: 11902299
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological impact of trametinib in pediatric low-grade glioma: A case series.
Peterson RK; McKeown T; Tabori U; Bartels U; Bouffet E; Janzen L
Pediatr Blood Cancer; 2020 Dec; 67(12):e28690. PubMed ID: 32930446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]